IMMNOV (IMMNOV) News
Track canonical SquawkNews coverage tagged to IMMNOV, IMMNOV. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Immunovia (IMMNOV) Calls EGM to Approve Dilutive Rights Issue
Immunovia AB (publ) will hold an EGM on Oct 29, 2026 to approve a rights issue of units (2 shares + 1 warrant TO 4) and amend Articles to raise capital/share limits. Record date Nov 5; subscription Nov 9—23; TO 4 exercis
EQUITY | Sep 28, 2026, 04:35 PM UTC
L
Immunovia AB (publ) (IMMNOV) Plans SEK 63M Rights Issue, 80% Covered
Immunovia will conduct a SEK 63M rights issue of units, subject to EGM approval, with ~SEK 50M (≈80%) covered by undertakings and a bottom guarantee. Proceeds will fund US commercialization of PancreaSure, clinical studi
NEWS | Sep 28, 2026, 04:31 PM UTC
L
Immunovia AB (IMMNOV) Files for Medicare LCD Coverage of PancreaSure
Immunovia AB submitted a formal request for a new Local Coverage Determination for PancreaSure, seeking Medicare coverage for its blood test for early detection of pancreatic cancer in high—risk individuals.Material Deta
NEWS | Sep 28, 2026, 12:01 PM UTC